Sujay Kango - Mar 30, 2022 Form 4 Insider Report for INFINITY PHARMACEUTICALS, INC. (INFI)

Role
Director
Signature
/s/ Seth A. Tasker, attorney-in-fact
Stock symbol
INFI
Transactions as of
Mar 30, 2022
Transactions value $
$0
Form type
4
Date filed
3/31/2022, 07:08 PM
Previous filing
Nov 23, 2021
Next filing
Jul 7, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INFI Stock Option (right to buy) Award $0 +90K $0.00 90K Mar 30, 2022 Common Stock 90K $1.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/8th of the total number of shares on March 31, 2022 and as to 1/8th of the total number of shares at the end of each calendar quarter thereafter, provided that the Reporting Person continues to serve as a Director of the Issuer.